Wolfe Research Downgrades Shockwave Medical to Peer Perform
Portfolio Pulse from Benzinga Newsdesk
Wolfe Research analyst Mike Polark has downgraded Shockwave Medical (SWAV) from Outperform to Peer Perform, indicating a change in the firm's outlook on the company.

April 05, 2024 | 8:48 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Shockwave Medical was downgraded by Wolfe Research from Outperform to Peer Perform, reflecting a more cautious view on the company's stock.
Analyst downgrades typically lead to a negative perception among investors, potentially causing a short-term decline in the stock price. The downgrade from Outperform to Peer Perform suggests Wolfe Research sees limited upside potential or increased risks that could hinder Shockwave Medical's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100